In this issue:
Low total IgE as a biomarker of nonresponse to omalizumab in CSU
Biomarkers of response to omalizumab in CSU
Mental health outcomes with omalizumab in CSU
MCID value for acupuncture treatment in CSU
Acupuncture in CSU: systematic review & meta-analysis
Efficacy & safety of 42 interventions in CSU
Barriers to self-administration of biologics
Safety & efficacy of remibrutinib in CSU
Barriers of adherence to treatment in CSU
Potential causal relationship between gut microbiota & CSU
Please login below to download this issue (PDF)